{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:39:15Z","timestamp":1767109155730,"version":"3.45.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jvacx.2022.100244","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:09:43Z","timestamp":1670249383000},"page":"100244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020"],"prefix":"10.1016","volume":"12","author":[{"given":"Marie","family":"Claire Endegue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Sein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Lopez Cavestany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Visalakshi","family":"Jeyaseelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tess","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gnakub","family":"Norbert Soke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aissata","family":"Diaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basit","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo A.","family":"Mainou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2022.100244_b0005","unstructured":"GPEI. GPEI-Global eradication of wild poliovirus type 2 declared. 2015."},{"key":"10.1016\/j.jvacx.2022.100244_b0010","unstructured":"CDC. Global Certification of Eradication of Indigenous Wild Poliovirus Type 3. CDC - Global Immunization - News and Views. 2019 2022-03-18T09:47:31Z."},{"key":"10.1016\/j.jvacx.2022.100244_b0015","unstructured":"WHO. Africa eradicates wild poliovirus Brazaville: @WHOAFRO; 2020 [Available from: https:\/\/www.afro.who.int\/news\/africa-eradicates-wild-poliovirus, accessed September 16 2022]."},{"key":"10.1016\/j.jvacx.2022.100244_b0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jvacx.2022.100244_b0025","doi-asserted-by":"crossref","first-page":"e1005728","DOI":"10.1371\/journal.ppat.1005728","article-title":"Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame","volume":"12","author":"Pons-Salort","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jvacx.2022.100244_b0030","unstructured":"WHO, GPEI. Global Wild Poliovirus 2016-2021 GPEI2021 [updated 30 November 2021. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2021\/12\/weekly-polio-analyses-WPV-20211130.pdf accessed September 16 2022]."},{"key":"10.1016\/j.jvacx.2022.100244_b0035","unstructured":"GPEI. Global Circulating Vaccine-Derived Poliovirus (cVDPV)- December 2021: World Health Organization (WHO); 2021 [Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2021\/12\/weekly-polio-analyses-cVDPV-20211207.pdf accessed September 16 2022]."},{"issue":"2","key":"10.1016\/j.jvacx.2022.100244_b0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4314\/ahs.v16i2.28","article-title":"Polio eradication efforts in regions of geopolitical strife: the Boko Haram threat to efforts in sub-Saharan Africa","volume":"16","author":"Bigna","year":"2016","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.jvacx.2022.100244_b0045","doi-asserted-by":"crossref","unstructured":"Unicef. Country Office Annual Report 2020 - Cameroon. 2020.","DOI":"10.5089\/9781513552606.002"},{"key":"10.1016\/j.jvacx.2022.100244_b0050","unstructured":"Unicef, WHO. Cameroon: WHO and UNICEF estimates of immunization coverage: 2020 revision. WHO and Unicef; 2021."},{"key":"10.1016\/j.jvacx.2022.100244_b0055","unstructured":"Icf INS. Enquete Demographique et de Sante 2018 - indicateurs cles 2018. Yaound\u00e9, Cameroun et Rockville, Maryland, USA : INS et ICF.: Institut National de la Statistique et ICF; 2020."},{"key":"10.1016\/j.jvacx.2022.100244_b0060","unstructured":"PASS 14 Power Analysis and Sample Size Software. Kaysville, Utah, USA: NCSS, LLC; 2015."},{"issue":"2","key":"10.1016\/j.jvacx.2022.100244_b0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jpids\/piab103","article-title":"A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad","volume":"11","author":"Gamougam","year":"2022","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"10.1016\/j.jvacx.2022.100244_b0070","article-title":"Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission\u2014Niger Experience. Open Forum","volume":"8(7):ofab210","author":"Ousmane","year":"2021","journal-title":"Infect Dis"},{"issue":"9","key":"10.1016\/j.jvacx.2022.100244_b0075","doi-asserted-by":"crossref","first-page":"e0185284","DOI":"10.1371\/journal.pone.0185284","article-title":"Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria","volume":"12","author":"Gofama","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2022.100244_b0080","doi-asserted-by":"crossref","unstructured":"Opare JKL, Akweongo P, Afari EA, Odoom JK. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana. Ghana Med J 2019;53(2):PMC6697761.","DOI":"10.4314\/gmj.v53i2.13"},{"issue":"12","key":"10.1016\/j.jvacx.2022.100244_b0085","first-page":"1414","article-title":"Survey of poliovirus antibodies in Kano","volume":"32","author":"Iliyasu","year":"2014","journal-title":"Northern Nigeria Vaccine"},{"key":"10.1016\/j.jvacx.2022.100244_b0090","unstructured":"Coates K. Want to Stop Polio? Vaccines are Crucial. But So Are Toilets. UN Dispatch. 2016 2016-03-09."},{"key":"10.1016\/j.jvacx.2022.100244_b0095","unstructured":"Joi P. The last mile of polio eradication and the vaccination challenges it brings: Gavi - Vaccines Work; 2020 [Available from: https:\/\/www.gavi.org\/vaccineswork\/last-mile-polio-eradication-and-vaccination-challenges-it-brings accessed September 16 2022]."},{"issue":"9","key":"10.1016\/j.jvacx.2022.100244_b0100","first-page":"668","article-title":"Coverage and costs of childhood immunizations in Cameroon","volume":"82","author":"Waters","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.jvacx.2022.100244_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-2557-9","article-title":"Mapping how information about childhood vaccination is communicated in two regions of Cameroon: What is done and where are the gaps?","volume":"15","author":"Ames","year":"2015","journal-title":"BMC Public Health"},{"issue":"49","key":"10.1016\/j.jvacx.2022.100244_b0110","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.15585\/mmwr.mm7049a1","article-title":"Update on Vaccine-Derived Poliovirus Outbreaks \u2014 Worldwide, January 2020\u2013June 2021","volume":"70","author":"Alleman","year":"2021","journal-title":"MMWR - Morb Mortal Wkly Rep"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222001048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136222001048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:08:26Z","timestamp":1762913306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136222001048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":22,"alternative-id":["S2590136222001048"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100244","relation":{},"ISSN":["2590-1362"],"issn-type":[{"type":"print","value":"2590-1362"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Community-based survey to assess seroprevalence of poliovirus antibodies in far-north Cameroon in 2020","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2022.100244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100244"}}